Search Results
Test Catalog
NIUC - Overview: Nickel/Creatinine Ratio, Random, Urine
Measurement of nickel concentration for biomonitoring nickel exposure
OXYSU - Overview: Oxycodone Screen, Random, Urine
Detection of oxycodone and oxymorphone in urine
OXYCX - Overview: Oxycodone with Metabolite Confirmation, Chain of Custody, Random, Urine
Detection and quantification of oxycodone, oxymorphone, noroxycodone, and noroxymorphone in urine Chain of custody is required whenever the results of testing could be used in a court of law. Its purpose is to protect the rights of the...
MUM1B - Overview: MUM-1/IRF4 Immunostain, Bone Marrow, Technical Component Only
Aiding in the identification of hematolymphoid neoplasms and melanomas
MOLPS - Overview: Molybdenum, Serum
Monitoring of parenteral nutrition Monitoring metallic prosthetic implant wear As an indicator of molybdenum cofactor deficiency
UPH24 - Overview: pH, 24 Hour, Urine
Assessment of patients with metabolic acidosis, crystalluria, as well as monitoring the effectiveness of alkalinization or acidification of urine for certain medical conditions (eg, treatment of uric acid nephrolithiasis) using a 24-hour...
STAT3 - Overview: Phosphorylated STAT3 at Tyrosine 705 (pSTAT3-Y705), Technical Component Only
Subclassification for anaplastic large cell lymphoma
CMVI - Overview: Cytomegalovirus (CMV) Immunostain, Technical Component Only
Identification of cytomegalovirus infection
DSS - Overview: Drug Screen, Prescription/Over the Counter, Serum
Detection and identification of prescription or over the counter drugs frequently found in drug overdose or used with a suicidal intent Qualitatively identifying drugs present in the specimen; quantification of identified drugs, when...
PDSUX - Overview: Drug Screen, Prescription/Over the Counter, Chain of Custody, Random, Urine
Qualitative detection and identification of prescription or over-the-counter drugs frequently found in drug overdose or used with a suicidal intent Providing, when possible, the identification of all drugs in the specimen This test is...
ETGS - Overview: Ethyl Glucuronide Screen, Random, Urine
Screening for drug abuse involving alcohol
CD15 - Overview: CD15 Immunostain, Technical Component Only
Phenotyping leukemias and lymphomas
CDOU - Overview: Cadmium Occupational Exposure, Random, Urine
Detecting occupational exposure to cadmium using random urine specimens
CLOM - Overview: Clomipramine, Serum
Determining whether a poor therapeutic response is attributable to noncompliance Monitoring serum concentration of clomipramine and norclomipramine to assist in optimizing the administered dose
ALCX - Overview: Ethanol, Chain of Custody, Blood
Detection of ethanol (ethyl alcohol) in blood to document prior consumption or administration of ethanol Quantification of the concentration of ethanol in blood correlates directly with degree of intoxication All testing is performed...
FENR - Overview: Fentanyl Screen with Reflex, Random, Urine
Screening for drug abuse or use involving fentanyl and confirmation of fentanyl if present in the screen
CLFIB - Overview: Fibrinogen, Clauss, Plasma
Detecting increased or decreased fibrinogen (factor 1) concentration of acquired or congenital origin Monitoring severity and treatment of disseminated intravascular coagulation and fibrinolysis
KRT5 - Overview: Keratin 5 (KRT5) Immunostain, Technical Component Only
Differentiation of mesothelioma and squamous cell carcinoma versus adenocarcinoma
MNU - Overview: Manganese, 24 Hour, Urine
Monitoring manganese exposure using 24 hour urine collections Nutritional monitoring
MET - Overview: Methemoglobin and Sulfhemoglobin, Blood
Diagnosing methemoglobinemia and sulfhemoglobinemia Identifying cyanosis due to other causes, such as congenital heart disease
LDPU - Overview: Limited Drug Profile, 3 Drug Classes, Immunoassay, Random, Urine
Detecting drug use involving barbiturates, cocaine, and carboxy-tetrahydrocannabinol This test is not intended for use in employment-related testing.
PBCU - Overview: Lead/Creatinine Ratio, Urine
Detecting clinically significant lead exposure using random urine specimens This test is not a substitute for blood lead screening.
KRT20 - Overview: Keratin 20 (KRT20) Immunostain, Technical Component Only
Aids in determining the primary site in carcinomas of unknown origin
PBUOE - Overview: Lead Occupational Exposure, Random, Urine
Detecting clinically significant lead exposure due to occupational exposure This test is not a substitute for blood lead screening.
MUM1 - Overview: MUM-1/IRF4 Immunostain, Technical Component Only
Aids in the identification of hematolymphoid neoplasms and melanomas
MUCN4 - Overview: Mucin 4, Immunostain, Technical Component Only
Aids in the differentiation of sarcomatoid carcinoma from sarcomatoid mesothelioma
MNCU - Overview: Manganese/Creatinine Ratio, Urine
Measurement of manganese as a part of a profile Monitoring manganese exposure Nutritional monitoring Clinical trials
MNRCU - Overview: Manganese/Creatinine Ratio, Random, Urine
Monitoring manganese exposure using random urine specimens Nutritional monitoring Clinical trials
MYGLU - Overview: Myoglobin, Random, Urine
Confirming the presence of a myopathy
Characterizing neoplasms of cytotoxic T cells or natural killer cells
TIBC - Overview: Total Iron Binding Capacity, Serum
Screening for chronic iron overload diseases, particularly hereditary hemochromatosis
SFZ - Overview: Sulfamethoxazole, Serum
Monitoring sulfamethoxazole therapy to ensure drug absorption, clearance, or compliance
TTF8G - Overview: Thyroid Transcription Factor (8G7G3/1) Immunostain, Technical Component Only
Identification of thyroid or lung cells as the primary tumor site in carcinomas of unknown origin
TLU - Overview: Thallium, 24 Hour, Urine
Detecting toxic thallium exposure in 24-hour urine collections
FRT4 - Overview: T4 (Thyroxine), Free, Serum
Evaluating suspected thyroid function disorders using free thyroxine measured together with thyroid-stimulating hormone
SIIRO - Overview: Sirolimus, Whole Blood
Monitoring whole blood sirolimus concentration during therapy, particularly in individuals coadministered cytochrome P450 (CYP) 3A4 substrates, inhibitors, or inducers Adjusting dose to optimize immunosuppression while minimizing...
SYNAP - Overview: Synaptophysin (SYNAPTO) Immunostain, Technical Component Only
Identification of neuronal tumors and tumors with neuroendocrine differentiation
TLUCR - Overview: Thallium/Creatinine Ratio, Random, Urine
Detecting toxic thallium exposure in random urine specimens
TIA1 - Overview: T-Cell Intracellular Antigen 1 (TIA-1) Immunostain, Technical Component Only
Characterizing neoplasms of cytotoxic T cells or natural killer cells
CYTH1 - Overview: T-Helper Cell Type 1 Cytokine Panel, Plasma
Assessment of plasma cytokine levels to understand the etiology of autoimmune and proinflammatory conditions when used in conjunction with clinical information and other laboratory testing
TACPK - Overview: Tacrolimus, Peak, Blood
Assessment of postdosing (peak) blood tacrolimus concentrations
STFR - Overview: Soluble Transferrin Receptor (sTfR), Serum
Evaluation of suspected iron deficiency in patients who may have inflammation, infection, or chronic disease and other conditions in which ferritin concentration does not correlate with iron status, including: -Cystic fibrosis patients who...
VZM - Overview: Varicella-Zoster Virus (VZV) Antibody, IgM, Serum
Diagnosing acute-phase infection with varicella-zoster virus
VLTUX - Overview: Volatile Screen, Chain of Custody, Random, Urine
Detecting the presence of acetone, methanol, isopropanol, or ethanol in urine with subsequent quantitation Providing chain of custody for when the results of testing could be used in a court of law. Its purpose is to protect the rights of...
BUPM - Overview: Buprenorphine and Norbuprenorphine, Random, Urine
Monitoring of compliance utilizing buprenorphine Detection and confirmation of the illicit use of buprenorphine
WT1I - Overview: Wilms Tumor (WT-1) Immunostain, Technical Component Only
Aiding in the identification of Wilms tumor
ZNUCR - Overview: Zinc/Creatinine Ratio, Random, Urine
Identifying the cause of abnormal serum zinc concentrations using a random urine specimen
Detecting zinc deficiency
ZONI - Overview: Zonisamide, Serum
Monitoring zonisamide therapy; recommended for all patients to ensure appropriate dosing Assessing medication compliance
EZNT8 - Overview: Zinc Transporter 8 (ZnT8) Antibody, Serum
Clinical distinction of type 1 from type 2 diabetes mellitus Identification of individuals at risk of type 1 diabetes (including high-risk relatives of patients with diabetes, and those with gestational diabetes) Prediction of future need...
Site Search
Mucopolysaccharidosis type I (MPS I) is a rare genetic disorder that typically presents with progressive multisystem involvement in early childhood. This condition results from the deficiency of the enzyme...
webinar on implementation of high-sensitivity troponin I assay - Insights
Cardiovascular Diseases, will be presenting a webinar on the implementation of a high-sensitivity troponin I assay. The webinar will be held February 13 from 1:00-2:00 p.m. eastern....
Should I Stay or Should I Go? - Insights
In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., and Rondell Graham, M.B.B.S., delve into the critical decisions involved in contemplating a role on the staff at the institution where you receive your training.
often oversimplified & misunderstood technology--Part I
In the last decade, genetic testing has evolved from single-gene Sanger based assays to much more complex next-generation sequencing (NGS) based assays.
inform novel treatments for kidney stones - Part I - Insights
A collaborative study between Mayo Clinic and the University of Illinois debunked the previous consensus about how kidney stones grow.